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Results: The median graft temperatures were significantly higher than the
target value of 4°C and varied widely (LD: 13.4–16.8°C; DD: 7.7–12.4°C).
The temperatures of DD grafts with normal initial function were significantly
lower than those in grafts with early allograft dysfunction (8.5°C (range, 6.6–
12.0°C) vs. 12.1°C (range, 9.2–15.7°C), p = 0.005). Only Glyc was signifi-
cantly different between DD and LD grafts (723 lmol/L (range, 397–1973
lmol/L) vs. 70 lmol/L (range, 53–75 lmol/L), p = 0.006).
The associations between [cold ischemia time * graft temperatures] and
metabolic parameters (Glucose, Lactate, Pyruvate, and Glycerol) were
investigated. The dotted lines on the graphs are the best results of dynamic
fitting using the equation: f = y0+a*exp (b*x). The R2 values for Glu, Lac,
and Glyc were 0.80, 0.60, and 0.81, respectively.
Conclusions: Not only the CIT but also the graft temperature affects the
state of metabolism and initial function. Thus, temperature monitoring com-
bined with microdialysis can be used for assessing graft quality and improv-
ing static cold storage technology.
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It has been worldwide showed that the machine perfusion (MP) offers many
benefits in liver transplantation, but it has still some grey area: costs are still
high, not all perfused grafts are implanted, the discard frequency after MP
preservation can be up to 12% and it is still reported PNF and EAD rate that
might be patient life threatening. The aim of the study is to assess the donor
risk factors of grafts, perfused with whatever MP, that would predict an inef-
fective MP setting up and those would trigger a EAD post-transplant.
Data from donors of all MP-perfused grafts have been analysed, whether they
were implanted or discarded after perfusion. First endpoint was the negative
events after perfusion (NegE), that is the number of grafts discarded plus
those were implanted but lost after the transplant. A risk factor analysis was
performed for NegE and marginal grafts for MP were identified. Finally, the
risk of EAD was investigated, considering only implanted grafts.
From 2015 to September 2019, 158 grafts were perfused with MP: 151
grafts were implanted and 7 discarded. Of 151, 15 grafts were lost after
transplant, therefore, the NegE group was of 22 donors. In the univariate
analysis, the donor risk index>1.7, the presence of hypertension in the past
medical history, the S-CIT and the moderate or severe macro-vesicular
steatosis were the significant factors for NegE. The multivariate analysis
confirmed the macro-steatosis>30% as an independent risk factor for NegE
(odd ratio 5.643, p = 0.023, 95%CI : 1.27–24.98).
Of 151 transplanted patients 34% of recipients experienced a EAD and had
a worse 1- &3-year-survival, comparing with those who don’t faced with
EAD (NoEAD), respectively 96% & 96% for EAD vs. 89% & 71% for
NoEAD, p = 0.03. No one of the donor/graft characteristics was associated
to EAD even if the graft was form aged donor, or moderately steatotic or
fibrotic or with elevated transaminase.
For the first time, this study shows that macro vesicular steatosis > 30%
might be a warning factor involved in graft lost risk or a graft discard cause
after the MP treatment. From the other side, the MP seems to be useful to
reduce the donor and graft weight in developing a EAD. More studied
needed to investigate other EAD factors to better prevent this fatal compli-
cation.
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Aims and Background: Acute kidney injury (AKI) is a major risk factor of
poor outcomes after liver transplantation (LT). AKI is usually attributed to
post-LT events and drug toxicity. Peri-operative risk factors of LT-associated
AKI remain poorly documented, which hampers the development of person-
alized preventive strategies.
Methods: AKI was assessed by KDIGO criteria based on creatinine
changes from baseline to day 5 post LT. 260 single first full-size LTs without
any pre-existing renal replacement therapy (RRT) were performed from
2003 to 2018. Incidence of AKI was assessed. Logistic regression deter-
mined the risk factors of KDIGO I and II-III AKI.
Results: Incidence of AKI KDIGO I and II-III was 30% (78/260) and 25.7%
(67/260), respectively. Preoperatively, patients with AKI had higher lab-
MELD and Child-Pugh scores, lower serum fibrinogen and albumin levels.
Donor type, donor hepatectomy and cold ischemic time were similar
between groups. AKI was more frequent in case of marginal donors. LT sur-
gery was longer in the AKI groups. Needs for per-operative blood transfu-
sions were higher in the AKI groups. Rate of post-reperfusion syndrome
was higher in AKI groups. Postoperatively, lower hemoglobin levels and
higher INR from day 1-5 were associated with AKI. Peak of transaminases
were not different between AKI versus non-AKI groups. AKI was associated
with longer length of hospital and ICU stays. After multivariate analysis,
blood transfusions and post-reperfusion syndrome were risk factors to
develop KDIGO I AKI. Pre-operative serum levels of fibrinogen and albumin
were risk factors for KDIGO II-III AKI. Finally, “marginal donors” was the
only risk factor for both KDIGO I and II-III AKI.
Conclusions: LT-associated AKI occurs in >50% of cases. Per-operative
hemorrhage and post-operative reperfusion syndrome represent risk factors,
particularly in cases of marginal donors.
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Background: Split liver transplantation increases organ availability. How-
ever, split grafts from deceased donors have prolonged ischemic times
leading to inferior outcomes compared to whole grafts. Hypothermic
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